You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 289 No. 17, May 7, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Medical News & Perspectives
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic

Researchers Probe Aortic Stenosis

An Active, Potentially Treatable Disease Process?

Mike Mitka

JAMA. 2003;289:2197-2198.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Chicago—An age-old problem may not be an old-age phenomenon as conventional wisdom has believed.

The cardiology community has long assumed that aortic stenosis is a wear-and-tear, degenerative process caused, in part, by a heart beating for many decades. But research over the past few years suggests a different, more active, cause—lipoprotein deposits and inflammation of the aortic valve, with resulting calcification and ossification.


Electron beam tomography allows physicians to detect calcification (indicated by the arrow) of the aortic valve that separates the aorta (Ao) from the left ventricle (LV). (Reproduced with permission from Budoff MJ et al. Acad Radiol. 2002;9:1122-1127.) (Photo credit: Association of University Radiologists)

And if it is an active process, then medical therapy, such as statins or angiotensin-converting enzyme (ACE) inhibitors, may delay or possibly prevent clinical aortic valvular disease, even allowing patients to avoid valve replacement surgery, said Kevin D. O'Brien, MD, at . . . [Full Text of this Article]


RELATED ARTICLES

Impact of Electron Beam Tomography, With or Without Case Management, on Motivation, Behavioral Change, and Cardiovascular Risk Profile: A Randomized Controlled Trial
Patrick G. O'Malley, Irwin M. Feuerstein, and Allen J. Taylor
JAMA. 2003;289(17):2215-2223.
ABSTRACT | FULL TEXT  

Improving Risk of Coronary Heart Disease: Can a Picture Make the Difference?
Philip Greenland
JAMA. 2003;289(17):2270-2272.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Angiotensin Receptor-1 Blocker Inhibits Atherosclerotic Changes and Endothelial Disruption of the Aortic Valve in Hypercholesterolemic Rabbits
Arishiro et al.
J Am Coll Cardiol 2007;49:1482-1489.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.